Related Experiment Videos
[The effects of statins on stroke and cardiovascular incidence in randomized, placebo-controlled trials with clinical
1II. Belgyógyászat-Kardiológia, Békés Megyei Képviselótestület Pándy Kálmán Kórház, Gyula.
Insights
Statins significantly reduce stroke incidence, offering benefits beyond cholesterol reduction. These findings suggest increased clinical use of statins for stroke prevention.
Area of Science:
- Cardiovascular Medicine
- Neurology
- Pharmacology
Context:
- Stroke is the third leading cause of death globally, with risk factors overlapping those of coronary heart disease.
- While some studies show weak correlation between cholesterol and stroke, others indicate a link between high cholesterol and non-hemorrhagic stroke.
- Large-scale statin trials have demonstrated a reduction in both coronary events and stroke incidence.
Purpose:
- To analyze the impact of statin therapy on stroke incidence.
- To explore potential mechanisms of statin action on stroke, including cholesterol-lowering and pleiotropic effects.
- To evaluate the clinical implications of statin use in reducing stroke events.
Summary:
- Meta-analyses show varying correlations between cholesterol and stroke risk.
- Statin trials reveal significant reductions in stroke incidence alongside decreased coronary events.
- Potential mechanisms include cholesterol reduction, plaque stabilization, improved endothelial function, antithrombotic properties, and vascular tone effects.
Impact:
- Statin therapy demonstrates a notable decrease in stroke incidence (10-31%) and coronary events (24-34%).
- The findings support the more frequent use of statins in clinical practice for comprehensive cardiovascular risk management.
- Further research into the specific mechanisms of statins' effects on stroke is warranted.
Abstract:
In the mortality statistics behind the coronary heart disease and cancer the stroke is the third leading cause of death. The risk factors of stroke and coronary heart disease are similar, but in a recent meta-analysis (Prospective Studies Collaboration) on 450,000 patients from 45 studies didn't find close correlation between the occurrence of stroke and the cholesterol level. In the Multiple Risk Factor Intervention Trial the incidence of haemorrhagic and non-haemorrhagic stroke was analysed separately and a significant correlation has been found between the high cholesterol level and occurrence of the non-haemorrhagic stroke. The great statin trials in a large scale of patients' groups (different cholesterol and risk levels at the inclusion) beside the decline of coronary events proved a decrease in stroke incidence too. The mechanism of action of the statins on stroke is not known: beside the cholesterol lowering effect the so called pleiotropic effects (plaque stabilisation, improvement of endothelial dysfunction and antithrombotic properties) and a direct effect on vascular tone could get importance. The fact that statins could improve the incidence of coronary events with 24-34%, that of stroke with 10-31%, suggests, that this drugs has to be used more frequently in the clinical practice.